Related Experiment Video
Updated: Feb 26, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained
Stephen T Vernon1,2, Sean Coffey1,3, Ravinay Bhindi1,2
11 Cardiothoracic and Vascular Health, Kolling Institute and Department of Cardiology, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, Australia.
Insights
The number of ST-elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors (SMuRFs) is increasing. This highlights a growing need for new diagnostic and therapeutic strategies for heart attack patients.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Standard Modifiable Cardiovascular Risk Factors (SMuRFs) management has improved cardiovascular disease (CVD) outcomes.
- CVD remains the leading global cause of death.
- Evolving risk factor profiles in ST-elevation myocardial infarction (STEMI) patients are suspected due to primary care advancements.
Purpose of the Study:
- To investigate the trend of STEMI patients presenting without SMuRFs.
- To test the hypothesis that the proportion of 'SMuRFless' STEMI cases has increased.
Main Methods:
- Retrospective analysis of consecutive STEMI patients from a single center (2006-2014).
- Assessment of the prevalence of SMuRFs (hypercholesterolaemia, hypertension, diabetes, smoking) at presentation.
- Statistical analysis to determine trends and associations.
Main Results:
- 25% of STEMI patients (132/695) had zero SMuRFs.
- The proportion of SMuRFless STEMI patients significantly increased from 11% in 2006 to 27% in 2014 (OR 1.12 per year).
- Decreases observed in hypercholesterolaemia and current smoking rates; no significant change in diabetes or hypertension prevalence.
Conclusions:
- A substantial and increasing proportion of STEMI cases are not explained by traditional SMuRFs.
- Urgent need for novel mechanisms, biomarkers, and targeted therapies for this growing patient group.
- Further research is required to understand the outcomes and develop new treatments for SMuRFless STEMI.
Abstract:
Aims Identification and management of the Standard Modifiable Cardiovascular Risk Factors (SMuRFs; hypercholesterolaemia, hypertension, diabetes and smoking) has substantially improved cardiovascular disease outcomes. However, cardiovascular disease remains the leading cause of death worldwide. Suspecting an evolving pattern of risk factor profiles in the ST elevation myocardial infarction (STEMI) population with the improvements in primary care, we hypothesized that the proportion of 'SMuRFless' STEMI patients may have increased. Methods/results We performed a single centre retrospective study of consecutive STEMI patients presenting from January 2006 to December 2014. Over the study period 132/695 (25%) STEMI patients had 0 SMuRFs, a proportion that did not significantly change with age, gender or family history. The proportion of STEMI patients who were SMuRFless in 2006 was 11%, which increased to 27% by 2014 (odds ratio 1.12 per year, 95% confidence interval: 1.04-1.22). The proportion of patients with hypercholesterolaemia decreased (odds ratio 0.92, 95% confidence interval 0.86-0.98), as did the proportion of current smokers (odds ratio 0.93, 95% confidence interval 0.86-0.99), with no significant change in the proportion of patients with diabetes and hypertension. SMuRF status was not associated with extent of coronary disease; in-hospital outcomes, or discharge prescribing patterns. Conclusion The proportion of STEMI patients with STEMI poorly explained by SMuRFs is high, and is significantly increasing. This highlights the need for bold approaches to discover new mechanisms and markers for early identification of these patients, as well as to understand the outcomes and develop new targeted therapies.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction